These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 19384598)

  • 21. Long-term protective effects of methamphetamine preconditioning against single-day methamphetamine toxic challenges.
    Hodges AB; Ladenheim B; McCoy MT; Beauvais G; Cai N; Krasnova IN; Cadet JL
    Curr Neuropharmacol; 2011 Mar; 9(1):35-9. PubMed ID: 21886558
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A robust increase in expression of arc gene, an effector immediate early gene, in the rat brain after acute and chronic methamphetamine administration.
    Kodama M; Akiyama K; Ujike H; Shimizu Y; Tanaka Y; Kuroda S
    Brain Res; 1998 Jun; 796(1-2):273-83. PubMed ID: 9689478
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MDMA ('Ecstasy') and methamphetamine combined: order of administration influences hyperthermic and long-term adverse effects in female rats.
    Clemens KJ; Cornish JL; Li KM; Hunt GE; McGregor IS
    Neuropharmacology; 2005 Aug; 49(2):195-207. PubMed ID: 15993443
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of methamphetamine self-administration on cortical monoaminergic deficits induced by subsequent high-dose methamphetamine administrations.
    McFadden LM; Hanson GR; Fleckenstein AE
    Synapse; 2013 Dec; 67(12):875-81. PubMed ID: 23893609
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Escalating dose-multiple binge methamphetamine exposure results in degeneration of the neocortex and limbic system in the rat.
    Kuczenski R; Everall IP; Crews L; Adame A; Grant I; Masliah E
    Exp Neurol; 2007 Sep; 207(1):42-51. PubMed ID: 17603040
    [TBL] [Abstract][Full Text] [Related]  

  • 26. GDNF selectively protects dopamine neurons over serotonin neurons against the neurotoxic effects of methamphetamine.
    Cass WA
    J Neurosci; 1996 Dec; 16(24):8132-9. PubMed ID: 8987838
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methamphetamine decreases calcium-calmodulin dependent protein kinase II activity in discrete rat brain regions.
    Suemaru J; Akiyama K; Tanabe Y; Kuroda S
    Synapse; 2000 Jun; 36(3):155-66. PubMed ID: 10819896
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methamphetamine self-administration causes persistent striatal dopaminergic alterations and mitigates the deficits caused by a subsequent methamphetamine exposure.
    McFadden LM; Hadlock GC; Allen SC; Vieira-Brock PL; Stout KA; Ellis JD; Hoonakker AJ; Andrenyak DM; Nielsen SM; Wilkins DG; Hanson GR; Fleckenstein AE
    J Pharmacol Exp Ther; 2012 Feb; 340(2):295-303. PubMed ID: 22034657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Behavioral sensitization and alteration in monoamine metabolism in mice after single versus repeated methamphetamine administration.
    Kitanaka N; Kitanaka J; Takemura M
    Eur J Pharmacol; 2003 Aug; 474(1):63-70. PubMed ID: 12909196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lobeline attenuates methamphetamine-induced changes in vesicular monoamine transporter 2 immunoreactivity and monoamine depletions in the striatum.
    Eyerman DJ; Yamamoto BK
    J Pharmacol Exp Ther; 2005 Jan; 312(1):160-9. PubMed ID: 15331654
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methamphetamine treatment during development attenuates the dopaminergic deficits caused by subsequent high-dose methamphetamine administration.
    McFadden LM; Hoonakker AJ; Vieira-Brock PL; Stout KA; Sawada NM; Ellis JD; Allen SC; Walters ET; Nielsen SM; Gibb JW; Alburges ME; Wilkins DG; Hanson GR; Fleckenstein AE
    Synapse; 2011 Aug; 65(8):771-7. PubMed ID: 21190217
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methamphetamine binge administration dose-dependently enhanced negative affect and voluntary drug consumption in rats following prolonged withdrawal: role of hippocampal FADD.
    García-Cabrerizo R; García-Fuster MJ
    Addict Biol; 2019 Mar; 24(2):239-250. PubMed ID: 29282816
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Escalating dose pretreatment induces pharmacodynamic and not pharmacokinetic tolerance to a subsequent high-dose methamphetamine binge.
    O'Neil ML; Kuczenski R; Segal DS; Cho AK; Lacan G; Melega WP
    Synapse; 2006 Nov; 60(6):465-73. PubMed ID: 16897726
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential effects of methamphetamine and SCH23390 on the expression of members of IEG families of transcription factors in the rat striatum.
    Beauvais G; Jayanthi S; McCoy MT; Ladenheim B; Cadet JL
    Brain Res; 2010 Mar; 1318():1-10. PubMed ID: 20059987
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regional-specific changes in rat brain BDNF in a model of methamphetamine abuse.
    Iamjan SA; Veerasakul S; Reynolds GP; Thanoi S; Nudmamud-Thanoi S
    Neurosci Lett; 2024 Jul; 836():137880. PubMed ID: 38885757
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epothilone D prevents binge methamphetamine-mediated loss of striatal dopaminergic markers.
    Killinger BA; Moszczynska A
    J Neurochem; 2016 Feb; 136(3):510-25. PubMed ID: 26465779
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-dose methamphetamine acutely activates the striatonigral pathway to increase striatal glutamate and mediate long-term dopamine toxicity.
    Mark KA; Soghomonian JJ; Yamamoto BK
    J Neurosci; 2004 Dec; 24(50):11449-56. PubMed ID: 15601951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of a cold environment or age on methamphetamine-induced dopamine release in the caudate putamen of female rats.
    Bowyer JF; Gough B; Slikker W; Lipe GW; Newport GD; Holson RR
    Pharmacol Biochem Behav; 1993 Jan; 44(1):87-98. PubMed ID: 8094252
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relation between methamphetamine-induced monoamine depletions in the striatum and sequential motor learning.
    Daberkow DP; Kesner RP; Keefe KA
    Pharmacol Biochem Behav; 2005 May; 81(1):198-204. PubMed ID: 15894079
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methamphetamine-induced changes in activity and water intake during light and dark cycles in rats.
    Kita T; Takahashi M; Wagner GC; Kubo K; Nakashima T
    Prog Neuropsychopharmacol Biol Psychiatry; 1998 Oct; 22(7):1185-96. PubMed ID: 9829297
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.